124
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review

, , , , , & show all
Pages 1627-1632 | Published online: 21 Jun 2017

References

  • KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
  • FavaMDavidsonKGDefinition and epidemiology of treatment-resistant depressionPsychiatr Clin North Am19961921792008827185
  • GaynesBNWardenDTrivediMHWisniewskiSRFavaMRushAJWhat did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depressionPsychiatr Serv200960111439144519880458
  • FervahaGFoussiasGTakeuchiHAgidORemingtonGMotivational deficits in major depressive disorder: cross-sectional and longitudinal relationships with functional impairment and subjective well-beingCompr Psychiatry2016663138
  • GuCZHeHLDuanHFSuZHChenHGanJLPredictors of neurocognitive impairment at 2 years after a first-episode major depressive disorderCompr Psychiatry2016682433
  • RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
  • KubitzNMehraMPotluriRCGargNCossrowNCharacterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims databasePloS One2013810e7688224204694
  • FrazerABenmansourSDelayed pharmacological effects of antidepressantsMol Psychiatry20027Suppl 1S23S2811986992
  • NaughtonMClarkeGO’LearyOFCryanJFDinanTGA review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of actionJ Affect Disord2014156243524388038
  • GalvezVNikolinSHoKAAlonzoASomogyiAALooCKIncrease in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trialCompr Psychiatry201773313427886522
  • BermanRMCappielloAAnandAAntidepressant effects of ket-amine in depressed patientsBiol Psychiatry200047435135410686270
  • PaulRSchaaffNPadbergFMollerHJFrodlTComparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two casesWorld J Biol Psychiatry200910324124419224412
  • FondGLoundouARabuCKetamine administration in depressive disorders: a systematic review and meta-analysisPsychopharmacology2014231183663367625038867
  • McGirrABerlimMTBondDJFleckMPYathamLNLamRWA systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodesPsychol Med201545469370425010396
  • ZarateCAJrSinghJBCarlsonPJA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depressionArchiv Gen Psychiatry2006638856864
  • PfenningerEGDurieuxMEHimmelseherSCognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteersAnesthesiology200296235736611818769
  • SinghJBFedgchinMDalyEIntravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled studyBiol Psychiatry201680642443126707087
  • GreenSMRothrockSGLynchELIntramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 casesAnn Emerg Med19983166886979624307
  • SinnerBGrafBMKetamineUrban BWSJSchwildenHHandbook Experimental PharmacologyBerlin, GermanySpringer2008313333
  • MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry19791344382389444788
  • W G. Clinical Impressions Scale (CGI)RushAJPincusHAFirstMBHandbook of Psychiatric MeasuresWashington, DCAmerican Psychiatric Association2000100102
  • LittellRCPendergastJNatarajanRModelling covariance structure in the analysis of repeated measures dataStat Med200019131793181910861779
  • DiazgranadosNIbrahimLBrutscheNEA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionArchiv Gen Psychiatry2010678793802
  • DiazGranadosNIbrahimLABrutscheNERapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorderJ Clin Psychiatry201071121605161120673547
  • ZarateCMachado-VieiraRHenterIIbrahimLDiazgranadosNSalvadoreGGlutamatergic modulators: the future of treating mood disorders?Harvard Rev Psychiatry2010185293303
  • MathewSJShahALapidusKKetamine for treatment-resistant unipolar depressionCNS Drugs201226318920422303887
  • LuckenbaughDANiciuMJIonescuDFDo the dissociative side effects of ketamine mediate its antidepressant effects?J Affect Disorders20141595661